Polish Journal of Public Health

Review Article, Pol J Public Health, Vol. 134 (2024): 4-7

Blanka Mitera, Karolina Harasimowicz, Marcin Donovan

  The School of Medical Law, University of Warsaw, Poland

 10.12923/2083-4829/2024-0002

© 2024 Author(s). This is an open access article distributed under the Creative Commons Attribution-NonComercial-No Derivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/

Abstract

This study delves into the evolution and current state of pharmaceutical care in Poland, the United States, and the United Kingdom,  highlighting similarities and differences in their approaches, regulations, and outcomes. Beginning with the legal frameworks governing pharmaceutical care, the analysis explores the progression of pharmaceutical services in each country over the past decade, emphasizing the focus on patient-centered care, evidence-based practices, and regulatory oversight. Key components of pharmaceutical care, such as medication management, adherence initiatives, and technological advancements, are examined within the context of each nation’s healthcare system. While all three countries prioritize patient well-being and accessibility to pharmaceutical services, variations emerge in government involvement, healthcare professional collaboration, pharmaceutical industry influence, medication accessibility, and cultural factors. Policymakers and healthcare practitioners seeking to enhance pharmaceutical care globally must acknowledge these distinctions to tailor interventions effectively.

Keywords: medication management service, the Patient-Centered Approach, rational drug usage, Pharmaceutical Care Practice, pharmacist’s contribution, healthcare outcome.